. BENGALURU: Cognizant is learnt to have secured a deal worth over $1 billion from Swiss pharma major Novartis as part of a consolidation contract that includes renewals as well as new scope spanning application services, infrastructure, data and AI-led offerings, people in the know told TOI. This marks the second consecutive billion-dollar deal for Cognizant in less than a year, after it won a large contract from UnitedHealth Group last year. UnitedHealth ranks among Cognizant’s biggest customers, supported by a partnership spanning nearly two decades. When TOI reached out, a Cognizant spokesperson said the company is currently in a silent period and had no comment. An email sent to Novartis did not elicit a response until the time of going to press. Those aware of developments said Cognizant’s EMEA and APAC teams played a key role in clinching the deal under the leadership of Gagan Syal, head of life sciences for EMEA and APAC at Cognizant. Phil Fersht, CEO of USIT advisory HfS Research, said the rise in half-billion-dollar and larger IT services deals reflects a structural reset in how enterprises buy technology, rather than a surge in discretionary spending. “CIOs are aggressively consolidating vendors, bundling what were once multiple mid-sized contracts into fewer, broader and longer-term engagements with clearer accountability. These deals now typically span seven to ten years.”About the AuthorShilpa PhadnisShilpa Phadnis is an Editor (IT) and Business Journalist with over 15 years of experience covering IT, business, and startups, capturing the city’s dynamic entrepreneurial ecosystem, GCCs, and new-age firms.Read MoreEnd of ArticleFollow Us On Social MediaVideos‘Attack On My Life’: Suvendu Adhikari Targets Mamata Banerjee, Levels Serious AllegationUkrainian Envoy Hails PM Modi As Global Leader, Praises Ukraine Peace EffortsChirag Paswan Hits Out At Tejashwi Yadav Over ‘People Lost In Democracy’ commentIndia’s Reform Express Accelerates Growth and Investment, Says PM ModiAmit Shah Confident BJP Will Form Government In Kerala In 2026, Vote Share ClimbingOwaisi Blames Congress, Hits Out at UAPA After SC Denies Bail To Umar Khalid‘Some Historians, Politicians Tried To Whitewash History Of Invaders’: PM Modi Hits Out In Somnath‘Hijab-Clad PM’ Row: Owaisi’s ‘Tubelight’ Jab At Himanta Sarma Over ‘Only Hindu PM’ RemarksRSS Chief Mohan Bhagwat Calls For Hindu Unity, Says India Will Lead World In 20–30 YearsPM Modi Offers Prayers At Somnath Temple, Witnesses Grand Drone Show & Fireworks At Swabhiman Parv123PhotostoriesSobhita Dhulipala’s most graceful saree looks – PicsHow to make Instant Rava Appe for breakfastCute parenting moments of Kareena Kapoor and Saif Ali KhanInside Nupur Sanon and Stebin Ben’s stylish Christian weddingLohri 2026: 11 must-try Punjabi dishes to celebrate Lohri‘The Raja Saab’: Educational qualification of the star cast10 things 90s kids begged their parents for, that Gen Z will be shocked even existed7 baby girl names inspired by Indian holy places that parents secretly love8 countries around the world most famous for their wildlifeSamantha Ruth Prabhu’s timeless saree looks that redefine elegance123Hot PicksTrump tariffsUS Supreme CourtGold rate todayBengaluru newsCigarette price hikePublic holidays January 2026Bank Holidays JanuaryTop TrendingUS Border Petrol Agent ShootCanada Immigration Applications 2026Kim KardashianVanessa BryantTrump TariffsConnor McDavidNFL PlayoffsAlex BregmanNandani SharmaFortnite Updates
BENGALURU: Cognizant is learnt to have secured a deal worth over $1 billion from Swiss pharma major Novartis as part of a consolidation contract that includes renewals as well as new scope spanning application services, infrastructure, data and AI-led offerings, people in the know told TOI. This marks the second consecutive billion-dollar deal for Cognizant in less than a year, after it won a large contract from UnitedHealth Group last year. UnitedHealth ranks among Cognizant’s biggest customers, supported by a partnership spanning nearly two decades. When TOI reached out, a Cognizant spokesperson said the company is currently in a silent period and had no comment. An email sent to Novartis did not elicit a response until the time of going to press. Those aware of developments said Cognizant’s EMEA and APAC teams played a key role in clinching the deal under the leadership of Gagan Syal, head of life sciences for EMEA and APAC at Cognizant. Phil Fersht, CEO of USIT advisory HfS Research, said the rise in half-billion-dollar and larger IT services deals reflects a structural reset in how enterprises buy technology, rather than a surge in discretionary spending. “CIOs are aggressively consolidating vendors, bundling what were once multiple mid-sized contracts into fewer, broader and longer-term engagements with clearer accountability. These deals now typically span seven to ten years.“